Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michel Roethlisberger has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effect of Semisitting Versus Supine Positioning on Intraoperative Bleeding During Endoscopic Endonasal Pituitary Surgery: A Randomized Clinical Trial

    by Jonathan Rychen, Tim J. Hallenberger, Florian S. Halbeisen, Luca L. Marques, Valentin F. Weiger, Ivan Polli, Laurent Muller, Manuel Petitat, Christoph Oetliker, Christian Mueller, et al.

    BACKGROUND AND OBJECTIVES: In endoscopic endonasal trans-sphenoidal pituitary surgery, the semisitting position (SSP) may reduce intraoperative bleeding compared with the supine position (SP); however, supporting evidence is lacking. The aim of this study was to compare the SSP with the SP and assess its effect on intraoperative bleeding. METHODS: This randomized, controlled, single-blind superiority trial was conducted at a Swiss tertiary hospital from 2021 to 2024. Of 107 patients screened, 64 were randomized and 56 included in the final analysis. In the intervention group, patients were placed in the SSP, with the torso elevated 30° and the legs raised, and compared with those in the SP. All patients were monitored for venous air embolism using a precordial Doppler. The primary outcome was intraoperative blood loss. Secondary outcomes included, among others, the frequency of interruptions for suctioning or hemostatic maneuvers, as well as the incidence of air embolism. RESULTS: Twenty-eight patients were allocated to each group. Most patients had a pituitary neuroendocrine tumor (25 [89.3%] in the SSP group and 27 [96.4%] in the SP group). The mean (SD) intraoperative blood loss was lower in the SSP group than in the SP group (184.7 [130.3] mL vs 277.3 [181.0] mL), corresponding to a mean reduction of 92.6 mL (33.4%) (95% CI, −177.1 to −8.1 mL; P = .03). Similarly, the median (IQR) frequency of intraoperative interruptions was lower in the SSP group than in the SP group (85.5 [62.3-109.0] vs 104.0 [77.5-135.5]), with a rate ratio of 0.80 (95% CI, 0.66-0.98; P = .03). Venous air embolism occurred in 3 patients (10.7%) in the SSP group and none in the SP group ( P = .09); all events were hemodynamically insignificant and resolved spontaneously. CONCLUSION: The SSP in endoscopic endonasal pituitary surgery reduces intraoperative bleeding and may improve surgical workflow, without raising major safety concerns.

  • Open Access

    Keyhole retrosigmoid approach for microvascular decompression surgery: systematic review and single-arm meta-analysis

    by Valentin F. Weiger, Florian S. Halbeisen, Felipe Constanzo, Michel Roethlisberger, Jehuda Soleman, Luigi Mariani, Raphael Guzman, Jonathan Rychen

    Microvascular decompression (MVD) surgery is traditionally performed via a retrosigmoid craniotomy. Recently, neurosurgeons have increasingly adopted smaller approaches; however, the available evidence has not yet been systematically compiled. This is the first systematic review and meta-analysis on the efficacy and safety of ≤ 2-cm-keyhole retrosigmoid MVD. PubMed and Embase databases were searched for studies involving adults with trigeminal neuralgia (TN), hemifacial spasm (HFS), or glossopharyngeal neuralgia (GPN), who underwent first-time retrosigmoid keyhole MVD (diameter ≤ 2 cm). Primary outcomes were symptom relief and complications. Study quality was assessed using the Methodological Index for Non-Randomized Studies (MINORS). Pooled estimates were calculated using a random-effects single-arm meta-analysis. 32 publications met the inclusion criteria. 93.7% had a retrospective design. The mean MINORS score was 9.9 ± 1.4 out of 16. Among 5,883 patients, 37.7% had TN, 61.6% HFS, and 0.7% GPN. The complete symptom resolution rate was 89.8% (95% CI [0.855–0.930]) for TN, 91.1% (95% CI [0.871–0.940]) for HFS and 88.7% (95% CI [0.746–0.954]) for GPN. The overall complication rate was 13.9% (95% CI, 0.107–0.180), with a permanent neurological deficit rate of 4.7% (95% CI, 0.030–0.074), all involving cranial nerves (CN). In patients with TN, the most frequent permanent neurological deficit was a sensory CN V deficit, occurring in 2.6% (95% CI, 0.013–0.050), followed by a CN VIII deficit in 1.9% (95% CI, 0.011–0.035). Among HFS patients, the most frequent permanent deficits were CN VIII in 5.0% (95% CI, 0.026–0.094) and CN VII in 2.1% (95% CI, 0.008–0.050). None of the studies described cases requiring conversion from a keyhole approach to a standard craniotomy. The keyhole retrosigmoid approach for MVD appears to be safe and effective. Comparative studies are needed to evaluate potential advantages of a keyhole approach over a standard craniotomy.


  • Open Access

    Assessment of Interrater Reliability and Accuracy of Cerebral Aneurysm Morphometry Using 3D Virtual Reality, 2D Digital Subtraction Angiography, and 3D Reconstruction: A Randomized Comparative Study

    by Attill Saemann, Daniel de Wilde, Jonathan Rychen, Michel Roethlisberger, Marek Żelechowski, Balázs Faludi, Philippe Claude Cattin, Marios-Nikos Psychogios, Jehuda Soleman, Raphael Guzman

    Background/Objectives: Detailed morphometric analysis of an aneurysm and the related vascular bifurcation are critical factors when determining rupture risk and planning treatment for unruptured intracranial aneurysms (UIAs). The standard visualization of digital subtraction angiography (DSA) and its 3D reconstruction on a 2D monitor provide precise measurements but are subject to variability based on the rater. Visualization using virtual (VR) and augmented reality platforms can overcome those limitations. It is, however, unclear whether accurate measurements of the aneurysm and adjacent arterial branches can be obtained on VR models. This study aimed to assess interrater reliability and compare measurements between 3D VR, standard 2D DSA, and 3D DSA reconstructions, evaluating the reliability and accuracy of 3D VR as a measurement tool. Methods: A pool of five neurosurgeons performed three individual analyses on each of the ten UIA cases, measuring them in completely immersed 3D VR and the standard on-screen format (2D DSA and 3D reconstruction). This resulted in three independent measurements per modality for each case. Interrater reliability of measurements and morphology characterization, comparative differences, measurement duration, and VR user experience were assessed. Results: Interrater reliability for 3D VR measurements was significantly higher than for 3D DSA measurements (3D VR mean intraclass correlation coefficient [ICC]: 0.69 ± 0.22 vs. 3D DSA mean ICC: 0.36 ± 0.37, p = 0.042). No significant difference was observed between 3D VR and 2D DSA (3D VR mean ICC: 0.69 ± 0.22 vs. 2D DSA mean ICC: 0.43 ± 0.31, p = 0.12). A linear mixed-effects model showed no effect of 3D VR and 3D DSA (95% CI = −0.26–0.28, p = 0.96) or 3D VR and 2D DSA (95% CI = −0.02–0.53, p = 0.066) on absolute measurements of the aneurysm in the anteroposterior, mediolateral, and craniocaudal dimensions. Conclusions: 3D VR technology allows for reproducible, accurate, and reliable measurements comparable to measurements performed on a 2D screen. It may also potentially improve precision for measurements of non-planar aneurysm dimensions.


  • Management of Recurrent Cerebrospinal Fluid Rhinorrhea Caused by Sequential, Anatomically Separated Skull Base Defects—A Case-Based Systematic Review

    by Tim Jonas Hallenberger, Jonathan Rychen, Jehuda Soleman, Juan C. Fernandez-Miranda, Yves Brand, Luigi Mariani, Michel Roethlisberger


  • Open Access

    Quality of Life After Poor-Grade Aneurysmal Subarachnoid Hemorrhage

    by Johannes Goldberg, Werner J. Z'Graggen, Martin Hlavica, Mattia Branca, Serge Marbacher, Donato D'Alonzo, Javier Fandino, Martin N. Stienen, Marian C. Neidert, Jan-Karl Burkhardt, et al.

    BACKGROUND: Poor-grade aneurysmal subarachnoid hemorrhage (aSAH) is associated with high mortality and poor disability outcome. Data on quality of life (QoL) among survivors are scarce because patients with poor-grade aSAH are underrepresented in clinical studies reporting on QoL after aSAH. OBJECTIVE: To provide prospective QoL data on survivors of poor-grade aSAH to aid clinical decision making and counseling of relatives. METHODS: The herniation World Federation of Neurosurgical Societies scale study was a prospective observational multicenter study in patients with poor-grade (World Federation of Neurosurgical Societies grades 4 & 5) aSAH. We collected data during a structured telephone interview 6 and 12 months after ictus. QoL was measured using the EuroQoL - 5 Dimensions - 3 Levels (EQ-5D-3L) questionnaire, with 0 representing a health state equivalent to death and 1 to perfect health. Disability outcome for favorable and unfavorable outcomes was measured with the modified Rankin Scale. RESULTS: Two hundred-fifty patients were enrolled, of whom 237 were included in the analysis after 6 months and 223 after 12 months. After 6 months, 118 (49.8%) patients were alive, and after 12 months, 104 (46.6%) patients were alive. Of those, 95 (80.5%) and 89 (85.6%) reached a favorable outcome with mean EQ-5D-3L index values of 0.85 (±0.18) and 0.86 (±0.18). After 6 and 12 months, 23 (19.5%) and 15 (14.4%) of those alive had an unfavorable outcome with mean EQ-5D-3L index values of 0.27 (±0.25) and 0.19 (±0.14). CONCLUSION: Despite high initial mortality, the proportion of poor-grade aSAH survivors with good QoL is reasonably large. Only a minority of survivors reports poor QoL and requires permanent care.


  • Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI

    by Sven Berkmann, Michel Roethlisberger, Beat Mueller, Mirjam Christ-Crain, Luigi Mariani, Egbert Nitzsche, Freimut Juengling

    Purpose 11-C-methionine (MET)-positron emission tomography (PET) as an adjunct to magnetic resonance imaging (MRI) has been proposed as a suitable molecular imaging modality for localizing pituitary adenomas in Cushing’s disease. 18-F-Fluoroethyl-L-tyrosine (FET)-PET, which is more widely available has not yet been reported in this context. Methods Retrospective double-center cohort study on 15 patients who underwent transsphenoidal surgery for biochemically proven Cushing’s disease between 2011 and 2019. Preoperative MET-PET/MRI and/or FET-PET/MRI were compared with intraoperative and histopathological examinations using the Mann Whitney U test and the Fisher’s Exact test, along with positive predictive value calculations. Results Fifteen patients were included, with a mean age of 47.2 (18–69) years. Six patients received either a MET-PET/MRI or a FET-PET/MRI and 3 patients both exams, respectively. 67% of the tumors were detected by MRI (MET-PET-group [56%]; FET-PET-group [78%]). All tumors were microadenomas with a mean adenoma volume of 0.19 cm3 (0.02–0.78), all of which displayed a circumscribed pathological FET- and/or MET-uptake. FET-PET/MRI results positively correlated with the localization of the tumor confirmed intraoperatively and histopathologically in all cases, resulting in a sensitivity and specificity of FET-PET/MRI for tumor localization of 100% (95% CI 66.37–100%). One MET-PET/MRI suggested a localization contralateral to the expected spot. The sensitivity and specificity of MET-PET for tumor localization hence was 89% (95% CI 51.75–99.72%). Conclusions Preoperative hybrid FET-PET/MRI and MET-PET/MRI have a high predictive value in localizing corticotroph adenoma for selective adenomectomy in Cushing’s disease.


  • Open Access

    Clinical Studies and Pre-clinical Animal Models on Facial Nerve Preservation, Reconstruction, and Regeneration Following Cerebellopontine Angle Tumor Surgery–A Systematic Review and Future Perspectives

    by Isabel C. Hostettler, Narayan Jayashankar, Christos Bikis, Stefan Wanderer, Edin Nevzati, Ravindran Karuppiah, Vicknes Waran, Daniel Kalbermatten, Luigi Mariani, Serge Marbacher, et al.

    Background and purpose: Tumorous lesions developing in the cerebellopontine angle (CPA) get into close contact with the 1st (cisternal) and 2nd (meatal) intra-arachnoidal portion of the facial nerve (FN). When surgical damage occurs, commonly known reconstruction strategies are often associated with poor functional recovery. This article aims to provide a systematic overview for translational research by establishing the current evidence on available clinical studies and experimental models reporting on intracranial FN injury.Methods: A systematic literature search of several databases (PubMed, EMBASE, Medline) was performed prior to July 2020. Suitable articles were selected based on predefined eligibility criteria following the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) guidelines. Included clinical studies were reviewed and categorized according to the pathology and surgical resection strategy, and experimental studies according to the animal. For anatomical study purposes, perfusion-fixed adult New Zealand white rabbits were used for radiological high-resolution imaging and anatomical dissection of the CPA and periotic skull base.Results: One hundred forty four out of 166 included publications were clinical studies reporting on FN outcomes after CPA-tumor surgery in 19,136 patients. During CPA-tumor surgery, the specific vulnerability of the intracranial FN to stretching and compression more likely leads to neurapraxia or axonotmesis than neurotmesis. Severe FN palsy was reported in 7 to 15 % after vestibular schwannoma surgery, and 6% following the resection of CPA-meningioma. Twenty-two papers reported on experimental studies, out of which only 6 specifically used intracranial FN injury in a rodent (n = 4) or non-rodent model (n = 2). Rats and rabbits offer a feasible model for manipulation of the FN in the CPA, the latter was further confirmed in our study covering the radiological and anatomical analysis of perfusion fixed periotic bones.Conclusion: The particular anatomical and physiological features of the intracranial FN warrant a distinguishment of experimental models for intracranial FN injuries. New Zealand White rabbits might be a very cost-effective and valuable option to test new experimental approaches for intracranial FN regeneration. Flexible and bioactive biomaterials, commonly used in skull base surgery, endowed with trophic and topographical functions, should address the specific needs of intracranial FN injuries.


  • Early permanent cerebrospinal fluid diversion in aneurysmal subarachnoid hemorrhage: does a lower rate of nosocomial meningitis outweigh the risk of delayed cerebral vasospasm related morbidity?

    by Davide Marco Croci, Martina Dalolio, Soheila Aghlmandi, Ethan Taub, Jonathan Rychen, Alessio Chiappini, Daniel Zumofen, Raphael Guzman, Luigi Mariani, Michel Roethlisberger

    Objective: Early permanent cerebrospinal fluid (CSF) diversion for hydrocephalus during the first 2 weeks after aneurysmal subarachnoid hemorrhage (aSAH) shortens the duration of external ventricular drainage (EVD) and reduces EVD-associated infections (EVDAI). The objective of this study was to detect any association with symptomatic delayed cerebral vasospasm (DCVS), or delayed cerebral ischemia (DCI) by the time of hospital discharge. Methods: We used a single-center dataset of aSAH patients who had received a permanent CSF diversion. We compared an ‘early group’ in which the procedure was performed up to 14 days after the ictus, to a ‘late group’ in which it was performed from the 15th day onward. Results: Among 274 consecutive aSAH patients, 39 (14%) had a permanent CSF diversion procedure with a silver-coated EVD. While the blood clot burden was similarly distributed, patients with early permanent CSF diversion (20 out of 39; 51%) had higher levels of consciousness on admission. Early permanent CSF diversion was associated with less colonized catheter, a shorter duration of extracorporeal CSF diversion (OR 0.73, 95%CI 0.58–0.92 per EVD day), and a lower rate of EVDAI (OR 0.08, 95%CI 0.01–0.80). The occurrence of CSF diversion device obstruction, the rate of symptomatic DCVS or detected DCI on computed tomography and the likelihood of a poor outcome at discharge did not differ between the two groups. Discussion: Early permanent CSF diversion lowers the occurrence of catheter colonization and infectious complication without affecting DCVS-related morbidity in good-grade aSAH patients. These findings need confirmation in larger prospective multicenter cohorts. Abbreviations: aSAH: aneurysmal subarachnoid hemorrhage; BNI: Barrow Neurological Institute Scale; CSF: Cerebrospinal fluid; DCVS: Delayed Cerebral Vasospasm; DCI: Delayed Cortical Ischemia; EKNZ: Ethik-Kommission Nordwest Schweiz; EVD: External ventricular drain; EVDAI: External ventricular drain-associated infections; GCS: Glasgow Coma Scale; IRB: Institutional Review Board; IVH: Inraventricular hemorrhage; mRS: Modified Rankin Scale; SOS: Swiss Study of Subarachnoid Hemorrhage Registry; WFNS: World Federation Neurological-Surgeon Scale


  • Open Access

    Early permanent cerebrospinal fluid diversion lowers the rate of nosocomial meningitis in aneurysmal subarachnoid hemorrhage

    by Davide Marco Croci, Martina Dalolio, Soheila Aghlmandi, Ethan Taub, Daniel Zumofen, Raphael Guzman, Luigi Mariani, Michel Roethlisberger

    Background: Early permanent cerebrospinal fluid (CSF) diversion for hydrocephalus after aneurysmal subarachnoid hemorrhage (aSAH) might shorten the duration of external ventricular drainage (EVD) and thereby reduce infectious complications. The potential effect on the rate of delayed cerebral vasospasm (DCVS) and associated morbidity has not been studied to date. The objective of this study was to detect any association with EVD-associated infections (EVDAI), symptomatic DCVS, or delayed cerebral ischemia (DCI) by the time of hospital discharge. Methods: A single-center dataset of aSAH patients who received a permanent CSF diversion procedure between 2009 and 2018 was used for the evaluation. The subjects were divided into an “early group” if such a procedure was performed up to 14 days after the ictus, and a “late group” if it was performed from the 15 th day onward. The statistical analysis employed univariable and multivariable logistic regression models. Results: Among 274 consecutive aSAH patients, 39 (14.2 %) had a permanent CSF diversion procedure. While the blood clot burden was similarly distributed, patients with early permanent CSF diversion (20 out of 39, 51.2%) had higher levels of consciousness on admission. Early permanent CSF diversion was associated with a shorter duration of EVD (OR 0.73, 95%CI 0.58-0.92 per day). Higher catheter colonization to EVDAI ratio (1/7 out of 20 vs. 7/7 out of 19) and a markedly lower frequency of EVDAI (OR 0.08, 95 %CI 0.01-0.80) were detected. The prevalence (5 vs. 37) and the cumulative incidence (3 vs. 18) of EVDAI were remarkably lower in patients receiving early permanent CSF diversion. The occurrence of CSF-diversion device obstruction, the rate of symptomatic DCVS (OR 0.61, 95 %CI 0.16-2.27) or detected DCI on computed tomography (OR 0.35, 95 %CI 0.08-1.47), and the likelihood of a poor outcome at discharge did not differ between the two groups (OR 0.88, 95%CI 0.24-3.22). Conclusions: Early permanent CSF diversion in good grade aSAH patients is associated with a shorter duration of EVD, lower catheter colonization rates, and fewer infectious complications. The timing of permanent CSF diversion had no detectable effect on DCVS-related morbidity. These findings need to be confirmed in larger cohorts.

  • Evolving Strategies for Resection of Sellar/Parasellar Synchronous Tumors via Endoscopic Endonasal Approach: A Technical Case Report and Systematic Review of the Literature

    by Michel Roethlisberger, Ronie Romelean Jayapalan, Isabel Charlotte Hostettler, Khairul Azmi Bin Abd Kadir, Kein Seong Mun, Yves Brand, Luigi Mariani, Narayanan Prepageran, Vicknes Waran